NIH-funded research R01 grant

Understanding how C. albicans invades human tissues

Official title: C. albicans invasive growth

Funded at State University New York Stony Brook · NIH-11012322 · Data updated 2026-11-12

This study is looking at how the fungus C. albicans changes from a harmless yeast to a harmful form that can cause serious infections, and it's for anyone interested in understanding how this fungus behaves in our bodies and how we might stop it from becoming dangerous.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionState University New York Stony Brook
NIH-funded
Lab location1 site (Stony Brook, United States)
Project startJanuary 17, 2024
Project endNovember 30, 2028
Funding year2025
Award (this year)$646,032
NIH project number5R01AI177553-02
Project IDNIH-11012322 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at high risk for C. albicans infections, such as those with weakened immune systems or underlying health conditions.

Less likely to help

Patients who do not have a history of C. albicans infections or are not at risk for such infections may not benefit from this research.

What this research studies

This research investigates the mechanisms by which the fungal pathogen C. albicans transitions from a harmless yeast form to an aggressive invasive form that can cause severe infections. By using genetic screening, the study aims to identify specific mutants that are less capable of invasive growth, focusing on the role of endocytosis and other novel functions in this process. The research will explore how these mechanisms operate both in laboratory settings and within the human body, providing insights into the pathogen's behavior during infections.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that prevent or reduce the severity of infections caused by C. albicans.

How similar studies have gone: Previous research has shown success in understanding fungal pathogenesis, but this specific approach to studying invasive growth mechanisms in C. albicans is relatively novel.

Where this research is happening

  • State University New York Stony Brook
    Stony Brook, United States
    Active

Researchers

  • Principal investigator: Konopka, James B — State University New York Stony Brook
  • Study coordinator: Konopka, James B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.